[ad_1]
Investment Research Report
[Baijiu Investment Daily]Has the high-end wine palette changed from Maotai to Wuliangye?
[Inversión diaria en vehículos de nueva energía]Which signal increases wholesale volume by 283%?
[Hardcore Research Report]New energy vehicles are leading the charge, this industry once again ushered in a dividend period? The national market share is over 60% and the international market share is almost 30%. The leading position in the industry is “somewhat stable” >>
[Hardcore Research Report]The carbon “culprit” has been found, and the energy structure will receive major changes! Non-net profit deduction skyrocketed by 130%, the best opportunity has arrived for the leading electrolytic aluminum industry.
Original title: The characteristic development of traditional Chinese medicine receives political support
On February 9, the General Office of the State Council issued the “Notice on Various Policies and Measures to Accelerate the Development of Traditional Chinese Medicine Characteristics,” which proposed measures to increase social investment, strengthen support for the channel of financing and optimize the management of the Chinese. drug review and approval. The industry believes that the Chinese medicine sector will usher in better development.
Create an industrial cluster
In terms of increasing social investment, the call proposes to promote qualified, competent and willing places to take the initiative, flexibly use local planning, land use, prices, insurance and financial support policies, encourage and guide social investment and improve clinical competitiveness of Chinese medicine, traditional Chinese medicine health service, mountainous area and thematic and industrial area.
In terms of strengthening support for financing channels, the notice proposes to actively support the listing and financing of rated Chinese medicine companies and the issuance of corporate credit bonds. Encourage social capital to start the establishment of investment funds for the Chinese medicine industry and increase long-term investment in the Chinese medicine industry. Encourage governments at all levels to comply with laws and regulations to support financial guarantee agencies to increase their guarantees for small and medium business bank loans in the field of Chinese medicine. Supporting credit service institutions to improve the credit information gathering and processing capabilities of the Chinese medicine industry, encouraging financial institutions to innovate financial products, and supporting the development of Chinese medicine with characteristics.
Yuekai Securities believes that in recent years, the growth rate of my country’s traditional Chinese medicine market has slowed, but the development base is solid, and several leading large-scale, high-efficiency and high-efficiency Chinese medicine companies have emerged. well known. . At present, there are more than 1,000 companies above the designated size in Chinese herbal medicines and more than 1,700 companies above the designated size in Chinese patent medicines. The Chinese medicine industry has 72 branded Chinese medicine companies.
Huachuang Securities believes that my country is the country with the richest traditional Chinese medicine resources in the world, and 70% of the natural medicinal plants in the international market come from China. With the development of science, people’s lives improve day by day, and the emphasis and understanding of the scientific medical treatment of Chinese medicinal materials increases, and the Chinese medicine industry will gain greater development opportunities.
The marginal upward trend is obvious
On February 9, the A-share Chinese medicine sector strengthened. At the closure,Don EjiaoDaily limit,Yunnan Baiyao、Renhe PharmaceuticalIncreased by more than 7%,Ma Yinglong、Xiangxue PharmaceuticalWait for 6 stocks to rise more than 5%.
Since 2020, the prices of Chinese medicinal materials have generally increased. According to Yaotong.com’s big data monitoring, there are 128 varieties with price increase in January 2021. Among them, Wang did not stay in business with a larger increase, from 6.5 yuan / kg to 12 yuan / kg. , an increase of 84.6%; Tianxian (North) increased from 30 yuan / kg to 50 yuan / kg, and Shamrock From 15 yuan / kg to 25 yuan / kg, the lotus (Shandong) increased from 140 yuan / kg to 220 yuan / kg, and the baiyaozi from 18 yuan / kg to 27 yuan / kg. Furthermore, the prices of Lonicera japonica, Purple Gloveria, Nelumbo nucifera (without sulfur) and dragon’s blood increased significantly.
Tianfeng ValuesHe said that considering that the Spring Festival is approaching and pharmaceutical consumption is expected to usher in a peak season, it is recommended that investors continue to focus on Chinese brand-name drugs that have the ability to increase prices. Overall, the Chinese medicine sector is expected to usher in a better development trend in 2021, and the marginal upward trend is obvious.
Sina Statement: This news is a reprint by Sina Cooperative Media. Posting this article on Sina.com for the purpose of conveying more information does not mean that I agree with their views or confirm their description. The content of the article is for reference only and does not constitute investment advice. Investors trade accordingly at their own risk.
Massive information, accurate interpretation, all in the Sina Finance APP
Editor-in-charge: Peng Jiabing
